Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | GSK3A | P49840 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10070690 | 0.97 | — | — | |
| SCHEMBL23625443 | 0.93 | ADRA2C (0.33) | ADRA2CGSK3AGSK3BMGLLMEN1 | |
| SCHEMBL2601688 | 0.82 | — | — | |
| SCHEMBL23664431 | 0.81 | GSK3A (0.33) | GSK3AGSK3B | |
| SCHEMBL16705492 | 0.71 | CRBN (0.32) | GSK3AGSK3BMGLLKMT2A | |
| SCHEMBL12220326 | 0.71 | ADRA2C (0.32) | ADRA2CGSK3AGSK3BMGLLMEN1 | |
| SCHEMBL10095225 | 0.69 | ADRA2C (0.30) | ADRA2CGSK3AGSK3BMGLLMEN1 | |
| SCHEMBL19975673 | 0.69 | LMNA (0.33) | GSK3AGSK3BMGLL | |
| SCHEMBL26415120 | 0.69 | CRBN (0.31) | ADRA2CGSK3AGSK3BMGLLMEN1 | |
| SCHEMBL9612275 | 0.69 | GSK3A (0.32) | GSK3AGSK3BMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230132686-A1 | STORAGE-STABLE POLYISOCYANATE COMPOSITION AND PREPARATION METHOD | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2023-05-04 | — | — | US | disclosed |
| EP-3383924-B1 | REDOX POLYMERIZABLE COMPOSITION WITH PHOTOLABILE REDUCING AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2021-04-14 | — | — | EP | disclosed |
| EP-2976323-B1 | HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS | 3M INNOVATIVE PROPERTIES CO (US) | 2020-07-15 | — | — | EP | disclosed |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-07-17 | — | — | US | disclosed |
| US-9988481-B2 | Polyisocyanate composition, coating composition, coating film and method for producing same, and humidity stabilization method | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-06-05 | — | — | US | disclosed |
| US-9951200-B2 | Thermoplastic compositions suitable for use in films | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-04-24 | — | — | US | disclosed |
| US-9921477-B2 | Photoactivable nitrogen bases | BASE SE (DE) | 2018-03-20 | — | — | US | disclosed |
| US-9907733-B2 | Dental compositions comprising addition-fragmentation agents | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-03-06 | — | — | US | disclosed |
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2018-02-15 | — | — | US | disclosed |
| US-20100068650-A1 | POSITIVE-WORKING RADIATION-SENSITIVE COMPOSITION AND METHOD FOR RESIST PATTERN FORMATION USING THE COMPOSITION | JSR CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20090258041-A1 | Protection of Oxidizable Agents | CIBA CORP. | 2009-10-15 | — | — | US | disclosed |
| WO-2009065743-A1 | RADIATION CURABLE COMPOSITIONS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2009-05-28 | — | — | WO | disclosed |
| US-20090092561-A1 | Body-care and household products and compositions comprising specific sulfur-containing compounds | BASF SE (DE) | 2009-04-09 | — | — | US | disclosed |
| US-20080305055-A1 | Anti-Radical Agents | CIBA CORPORATION | 2008-12-11 | — | — | US | disclosed |
| US-7410940-B2 | Antioxidants for the stabilization of surfactant formulations | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-08-12 | — | — | US | disclosed |
| EP-1073686-B1 | METHOD FOR PREPARING LOW VISCOSITY TRICONDENSATE POLYFUNCTIONAL ISOCYANATES | RHODIA CHIMIE SA (FR) | 2008-05-14 | — | — | EP | disclosed |
| US-20080108540-A1 | Antioxidants for the stabilization of formulations comprising surfactants | HUEGLIN DIETMAR | 2008-05-08 | — | — | US | disclosed |
| US-20080003438-A1 | Heterocyclic siloxanes for use in biocidal coatings and materials | AUBURN UNIVERSITY (US) | 2008-01-03 | — | — | US | disclosed |
| US-7288213-B1 | Method for preparing low viscosity tricondensate polyfunctional isocyanates | RHODIA CHIMIE (FR) | 2007-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044448-A1 | ADDITION-FRAGMENTATION OLIGOMERS | ECPAS, ITGA8, NBAS | ADRA2C 3676/4885GSK3A 4396/4885GSK3B 4451/4885 |
| US-20080305055-A1 | Anti-Radical Agents | NOS3, GSTO1, PTGS1 | ADRA2C 810/4885GSK3A 2084/4885GSK3B 2175/4885 |
| US-20090258041-A1 | Protection of Oxidizable Agents | LPO, TYR, HAO2 | ADRA2C 1948/4885GSK3A 4359/4885GSK3B 4531/4885 |
| US-20090092561-A1 | Body-care and household products and compositions comprising specific sulfur-containing compounds | DSC1, SCLY, DSG1 | ADRA2C 4801/4885GSK3A 4754/4885GSK3B 4664/4885 |
| US-10022306-B2 | Dental compositions comprising a fatty mono(meth)acrylate | MMAB, ELOVL5, ELOVL1 | ADRA2C 4299/4885GSK3A 4218/4885GSK3B 4600/4885 |
| US-20180217498-A1 | PHOTOACTIVABLE NITROGEN BASES | CBR1, NR0B1, NR0B2 | ADRA2C 587/4885GSK3A 3665/4885GSK3B 3528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.